Tim Watkins serves as Executive at Contineum Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Tim Watkins has executed 2 insider transactions totaling $43.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 29, 2025 involved exercising options for 3,611 shares valued at $16.2K.
Tim Watkins currently holds 3,611 shares of Contineum Therapeutics, Inc. (CTNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tim Watkins has been a net seller of CTNM stock. They have purchased $0 and sold $43.5K worth of shares.
Tim Watkins's most recent insider trade was on Dec 29, 2025, when they sold 3,611 shares at $4.50 per share.
Get notified when new Form 4 filings are submitted
| $12.06 |
| Discretionary |